Evidence map›Paper›PMID 28892734›Full record

Trial reportPsychiatry research. Neuroimaging2017

Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.

Brian P Brennan, Roee Admon, Chris Perriello, Erin M LaFlamme, Alison J Athey, Diego A Pizzagalli, James I Hudson, Harrison G Pope, J Eric Jensen

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Psychiatry research. Neuroimaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Brian P BrennanBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: bbrennan@partners.org.
Roee AdmonDepartment of Psychology, University of Haifa, Haifa, Israel.
Chris PerrielloBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA.
Erin M LaFlammeBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA.
Alison J AtheyDepartment of Psychological Sciences, Case Western Reserve University, Cleveland, OH, USA.
Diego A PizzagalliCenter for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA; McLean Imaging Center, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
James I HudsonBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Harrison G PopeBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
J Eric JensenMcLean Imaging Center, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
McLean Hospital · USHarvard University · USCase Western Reserve University · USUniversity of Haifa · IL

Funding

Neuroimaging Studies of Reward Processing in DepressionR37MH068376 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI Diego A Pizzagalli · 2016 to 2026
$7.4M
Glutamatergic Mediators of Antidepressant Response in Major DepressionK23MH092397 · NIMH · MCLEAN HOSPITAL · PI BRENNAN, BRIAN P. · 2011 to 2015
$895k
NIMH NIH HHS K23 MH092397NIMH NIH HHS R37 MH068376
6 · The paper itself

Abstract

Little is known about the acute effects of antidepressant treatments on brain glutamate and gamma-amino-butyric acid (GABA) levels, and their association with clinical response. Using proton magnetic resonance spectroscopy (

Indexed as

AdultAntidepressive AgentsCitalopramFemalegamma-Aminobutyric AcidGlutamic AcidGlutamineGyrus CinguliHumansLongitudinal StudiesMagnetic Resonance SpectroscopyMajor Depressive DisorderMaleMiddle AgedYoung AdultAntidepressive AgentsCitalopramgamma-Aminobutyric AcidGlutamic AcidGlutamineDepressionGABAGlutamateMagnetic resonance spectroscopyMRSSSRI

Identifiers

PMID28892734
PMCPMC5642118
OpenAlexW2750927378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.